Kevin Patrick Lynch
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Profilo
Kevin Patrick Lynch worked as a Vice President at Celgene Corp.
from 2011 to 2019.
He also worked as a Medical Director-Oncology at Novartis Pharmaceuticals Australia Pty Ltd.
and as an Executive Director & Chief Medical Officer at Antengene Corp.
Ltd.
in 2021.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
16/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Precedenti posizioni note di Kevin Patrick Lynch
Società | Posizione | Fine |
---|---|---|
ANTENGENE CORPORATION LIMITED | Chief Tech/Sci/R&D Officer | 16/12/2022 |
CELGENE | Corporate Officer/Principal | 01/01/2019 |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ANTENGENE CORPORATION LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Health Technology |
- Borsa valori
- Insiders
- Kevin Patrick Lynch